絞り込み

17057

広告

Cell-free DNA V600E measurements during BRAF inhibitor therapy of metastatic melanoma: long-term analysis.

著者 Kozak K , Kowalik A , Gos A , Wasag B , Lugowska I , Jurkowska M , Krawczynska N , Kosela-Paterczyk H , Switaj T , Teterycz P , Klimczak A , Siedlecki JA , Chlopek M , Kalisz J , Limon J , Rutkowski P
Tumori.2020 Feb 06 ; ():300891619900928.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (2view , 0users)

Full Text Sources

Miscellaneous

We assessed the status of the V600E mutation in cell-free circulating tumor DNA (cfDNA) isolated from the plasma of patients with metastatic melanoma treated with the BRAF inhibitor vemurafenib, collected at different time points during therapy to evaluate the sensitivity and specificity of quantitative polymerase chain reaction and droplet digital polymerase chain reaction (ddPCR) and the correlation between the level of plasma cfDNA p.V600E and the long-term clinical outcome.
PMID: 32026754 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード